1-3 of 3
Erika Buchholz
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cetuximab Attenuates Metastasis and u-PAR Expression in Non–Small Cell Lung Cancer: u-PAR and E-Cadherin are Novel Biomarkers of Cetuximab Sensitivity

Available to Purchase
Dessislava A. Nikolova, Irfan A. Asangani, Laura D. Nelson, Dennis P.M. Hughes, Doris R. Siwak, Gordon B. Mills, Andrea Harms, Erika Buchholz, Lothar R. Pilz, Christian Manegold, Heike Allgayer
Journal: Cancer Research
Cancer Res (2009) 69 (6): 2461–2470.
https://doi.org/10.1158/0008-5472.CAN-08-3236
Published: 17 March 2009
View articletitled, Cetuximab Attenuates Metastasis and u-PAR Expression in Non–Small Cell Lung Cancer: u-PAR and E-Cadherin are Novel Biomarkers of Cetuximab Sensitivity
Open the PDF for Cetuximab Attenuates Metastasis and u-PAR Expression in Non–Small Cell Lung Cancer: u-PAR and E-Cadherin are Novel Biomarkers of Cetuximab Sensitivity in another window
Includes: Supplementary data
Journal Articles

Cetuximab attenuates EGF induced u-PAR expression: Study on the anti-metastatic potential of Cetuximab in NSCLC

Free
Dessislava Nikolova, Irfan Asangani, Sak Rasheed, Laura Nelson, Dpm Hughes, Gordon Mills, Stefan Post, Erika Buchholz, Christian Manegold, Heike Allgayer
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 1175.
Published: 01 May 2008
View articletitled, Cetuximab attenuates EGF induced u-PAR expression: Study on the anti-metastatic potential of Cetuximab in NSCLC
Journal Articles

Hypermethylation pattern of serum-derived genomic DNA in Pemetrexed-treated mesothelioma patients

Free
Michael Kostrzewa, Michael Meister, Erika Buchholz, Thomas Muley, Ute Ohnmacht, Clemens Stoffregen, Christian Manegold, Jürgen R. Fischer, Harald Lahm
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 653.
Published: 01 May 2005
View articletitled, Hypermethylation pattern of serum-derived genomic DNA in Pemetrexed-treated mesothelioma patients